Effect of deferoxamin on stroke

Phase 2

• Conditions: Condition 1: stroke. Condition 2: intracerebral haemorrhage.; Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries; Sequelae of intracerebral haemorrhage

• Registration Number: IRCT2013111915444N2
• Lead Sponsor: Vice chancellor for research, Ahvaz Jondishapur University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

Acute ischemic stroke in middle cerebral artery territory. Exclusion criteria: renal failure; hemorrhagic stroke; stroke in other arterial territory; coagulopathies and history of anticoagulant drugs; anemia

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Serrum ferritin. Timepoint: First and fourth day of addmission. Method of measurement: Microgram per litre with ferritin test kit.

Secondary Outcome Measures

Name	Time	Method
Hemorrhagic transformation. Timepoint: Fourth and seventh day. Method of measurement: CT scan.